Journal profile · CHEMISTRY, MEDICINAL-CHEMISTRY, MULTIDISCIPLINARY
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH
ISSN 0004-4172 · eISSN 2194-9387 · GERMANY
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH: impact factor 2.1 (journal website); subscription journal; APC about USD 3,620; 0 articles in 2025.
Scope
Aims, scope and focus
By OpenAlex counts of its recent articles, ARZNEIMITTELFORSCHUNG-DRUG RESEARCH's largest topics are Analytical Methods in Pharmaceuticals, Synthesis and biological activity and Pharmacogenetics and Drug Metabolism, together about 35.3% of its articles. Its main subfields are Pharmacology. (generated from OpenAlex topic counts and CAS ranking data)
Target ReadershipDrug Research is intended for scientists, clinicians, and professionals involved in drug discovery, drug development, translational medicine, pharmacology, toxicology, and the evaluation of therapeutic compounds. It serves researchers working with both novel and established drug molecules, as well as those engaged in clinical trials, industrial investigations, and the quantitative assessment of drug efficacy and safety.Journal Purpose and MissionDrug Research (formerly Arzneimittelforschung) is an international peer‑reviewed journal with expedited processing times presenting the very latest research results related to novel and established drug molecules and the evaluation of new drug development. A key focus of the publication is translational medicine and the application of biological discoveries in the development of drugs for use in the clinical environment. The journal also addresses the mathematical and statistical methods for evaluating results from industrial investigations and clinical trials.Types of Articles PublishedDrug Research publishes the following article types, Original Article, Review, Short Communication, Commentary, Letter, Controversy, and Opinion Paper.Publication FrequencyDrug Research publishes 12 issues per annum.Subject and Content ScopeThe journal presents research related to novel and established drug molecules and the evaluation of new drug development. Its scope includes translational medicine and the application of biological discoveries to clinical drug development, as well as analytics applied to clinical trials, chemistry and biochemistry, clinical and experimental pharmacology, drug interactions, efficacy testing, pharmacodynamics, pharmacokinetics, teratology, and toxicology. It also encompasses the mathematical and statistical methods used to evaluate results from industrial investigations and clinical trials.
From the journal's Aims & Scope
Research area (LetPub): CHEMISTRY, MEDICINAL-CHEMISTRY, MULTIDISCIPLINARY
Editor-in-chief Thomas GudermannPublisher website
Editorial board by country: 2 in mainland China (about 13%); most named Germany 8, Mainland China 2, Switzerland 2, South Korea 1, France 1 (15 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Analytical Methods in PharmaceuticalsChemistry13%
- Synthesis and biological activityChemistry12.1%
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics10.3%
- Statistical Methods in Clinical TrialsMathematics8%
- Pharmaceutical studies and practicesMedicine5.9%
- Synthesis and Characterization of Heterocyclic CompoundsChemistry4.4%
- Biosimilars and Bioanalytical MethodsImmunology and Microbiology3.9%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
Indexed in: no record yet.
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
SSCIEmbasePublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2.1Publisher website ·
- 5-year impact factor (publisher)
- 1.9Publisher website ·
- h-index
- 57OpenAlex ·
- i10-index
- 616OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 2,165 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 225 |
| 2025 | 0 | 0 | 531 |
| 2024 | 0 | 0 | 712 |
| 2023 | 0 | 0 | 769 |
| 2022 | 0 | 0 | 888 |
| 2021 | 0 | 0 | 1,022 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | EUR 3,390 / USD 3,620 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 3–6
- Reference style
- Numbered, in order of citation
- First submission
- Free format: the journal's layout is not required
- Cover letter
- Required
Article types accepted13
- commentariesThe following manuscript types are published in Drug Research: Original Articles Reviews CommentariesLength not stated
- commentaryDrug Research publishes the following article types, Original Article, Review, Short Communication, Commentary, Letter, Controversy, and Opinion Paper.Length not stated
- controversiesThe following manuscript types are published in Drug Research: Original Articles Reviews Commentaries ControversiesLength not stated
- letterDrug Research publishes the following article types, Original Article, Review, Short Communication, Commentary, Letter, Controversy, and Opinion Paper.Length not stated
- lettersThe following manuscript types are published in Drug Research: Original Articles Reviews Commentaries Controversies Opinion Papers Short Communications LettersLength not stated
- opinionDrug Research publishes the following article types, Original Article, Review, Short Communication, Commentary, Letter, Controversy, and Opinion Paper.Length not stated
- opinion papersThe following manuscript types are published in Drug Research: Original Articles Reviews Commentaries Controversies Opinion PapersLength not stated
- original articleDrug Research publishes the following article types, Original Article, Review, Short Communication, Commentary, Letter, Controversy, and Opinion Paper.Length not stated
- original articlesThe following manuscript types are published in Drug Research: Original ArticlesLength not stated
- reviewDrug Research publishes the following article types, Original Article, Review, Short Communication, Commentary, Letter, Controversy, and Opinion Paper.Length not stated
- reviewsThe following manuscript types are published in Drug Research: Original Articles ReviewsLength not stated
- short communicationDrug Research publishes the following article types, Original Article, Review, Short Communication, Commentary, Letter, Controversy, and Opinion Paper.Length not stated
- short communicationsThe following manuscript types are published in Drug Research: Original Articles Reviews Commentaries Controversies Opinion Papers Short CommunicationsLength not stated
Policy excerpts from the journal's websiteConflicts of interest, Open access, Preprints
- Conflicts of interest Conflict of Interest
Conflict of interest declaration required for all authors during submission. Model summary
Please state the conflicts of interest of all authors during the online submission process. Failure to do so or an incomplete declaration may result in non-publication.
Source ↗Publisher website ·- Open access Publish Open Access
Online-only submission via ScholarOne (mc.manuscriptcentral.com/drugres). Model summary
Authors of articles for all Thieme subscription journals – including, of course, Drug Research - have the option of paying an article processing charge (APC) so that their articles will be published on an Open Access basis. Learn more about Thieme’s Open Access program by visiting https://www.thieme.com/en-us/who-we-serve/authors/journals/open-access. For the current pricing, please go to “APC” an…
Source ↗Publisher website ·- Preprints Preprint Server Statement
Drug Research encourages the submission of manuscripts that have been deposited in an initial draft version in preprint repositories such as Research Square, arXiv, and medRxiv. Drafts of short conference abstracts or degree theses posted on the website of the degree-granting institution, and draft manuscripts deposited on authors’ or institutional websites are also welcome. All other prior public…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Country or region
- GERMANY
- ISSN
- 0004-4172
- Print ISSN
- 2194-9379
- Electronic ISSN
- 2194-9387
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about ARZNEIMITTELFORSCHUNG-DRUG RESEARCH
What is the impact factor of ARZNEIMITTELFORSCHUNG-DRUG RESEARCH?
The journal's website gives an impact factor of 2.1; this is the journal's own figure, as LetPub lists none for it; h-index 57.
What are the manuscript requirements of ARZNEIMITTELFORSCHUNG-DRUG RESEARCH?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 3–6; Reference style: Numbered, in order of citation; First submission: Free format: the journal's layout is not required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of ARZNEIMITTELFORSCHUNG-DRUG RESEARCH based?
Of the 15 board members whose country the journal's board page names, 2 (about 13%) are in mainland China; the countries named most often are Germany (8), Mainland China (2) and Switzerland (2). Counted from the institutions listed on the board page; for reference only.
Which databases index ARZNEIMITTELFORSCHUNG-DRUG RESEARCH?
The journal's website lists SSCI and Embase; that list has not been checked against each database.
Is ARZNEIMITTELFORSCHUNG-DRUG RESEARCH open access, and what is the APC?
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH is a subscription journal. APC about USD 3,620.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .